<DOC>
	<DOCNO>NCT02344849</DOCNO>
	<brief_summary>This phase I clinical trial design evaluate safety autologous Mesenchymal Stem Cells ( MSC ) inject intracavernously .</brief_summary>
	<brief_title>Safety Autologous Bone Marrow Derived Mesenchymal Stem Cells Erectile Dysfunction</brief_title>
	<detailed_description>Cellgram-ED autologous bone marrow-derived mesenchymal stem cell ex vivo expand approximately 30 day . Ten patient ( Diabetes -associated ED ; 5 patient , Postprostatectomy ; 5patients ) inject Cellgram-ED directly intracavernous . Patient evaluate safety potential efficacy MSC .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Postprostatectomy Erectile Dysfunction A man age 20 older Who willing consent participate study concern improve sexual activity prostatectomy , man maintain normal sexual activity prior prostatectomy Prior prostatectomy PSA ( prostate specific antigen ) level &lt; 10 ng/mL At time Prostatectomy , Pathological Gleason sum ≤7 At time Prostatectomy , Pathological stage ≤ T2c 2 year postprostatectomy patient PSA level ≤ 0.04 ng/mL without additional therapy prostatectomy Who satisfy sexual activity ( 4 time ) proper sexual stimulation spite take maximum dose oral PDE5I ( phosphodiesterasetype5 inhibitor ) within last 8weeks . IIEF , EF ( erectile function ) domain score 17 Have consistent partner willing engage sexual activity twice per month study . Diabetesassociated Erectile Dysfunction HbA1c 6.5 % 10 % man 20 year age diabetes Who satisfy sexual activity ( 4 time ) proper sexual stimulation spite take maximum dose oral PDE5I within last 8weeks . IIEF , EF domain score 17 Who willing consent participate study concern improve sexual activity Have consistent partner willing engage sexual activity twice per month study . History bone marrow disorder Serum AST/ALT &gt; 3 X upper limit normal Creatinine &gt; 1.5 X upper limit normal History hypersensitivity gentamycin Severe cardiovascular disease ( angina , arrhythmia , cardiac failure , stroke ) , kidney failure , respiratory failure Positive human immunodeficiency virus ( HIV ) , hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) syphilis test Positive PSA CEA AFP ( Carcinoembryonic antigen ) , history cancer last five year ( except Prostatic cancer ) Uncontrolled hypertension hypotension ( systolic blood pressure &gt; 170 &lt; 90 mm Hg , diastolic pressure &gt; 100 &lt; 50 mm Hg ) HbA1c exhibit great 10 % Men anticoagulant treatment Have severe infectious disease Testosterone level less 200ng/dl Have penile implant willing Patients morphological change penis Patient 's partner try conceive trial period Unwilling participate study Participating clinical trial past 30 day Unable compliance protocol Inappropriate patient participate study accord investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>